I’ve spent close to 15 years helping biopharma and advanced therapy companies digitize business needs across brand teams, patient operations, commercial operations, and IT. Over that time, I’ve worked on more than a dozen patient services case management platform implementations. 

While every implementation had its own nuances, they all shared one defining characteristic: an unwavering commitment to delivering the best possible service to patients. Every client aspired to provide a true “white-glove” experience. 

At a high level, patient journeys often look similar: intake, benefits verification, prior authorization, free drug programs, patient assistance, and so on. But once you move beyond the surface, the details within each of these stages quickly become complex. It wasn’t uncommon for individual workflow decisions to require weeks, or even months, of discussion. Those conversations were where the real learning happened. 

Where the Complexity Truly Lies 

Looking back, roughly 60–70% of implementation discussions were concentrated on patient access, specifically on getting patients to their first dose as quickly and smoothly as possible. 

Breaking that down further: 

• Intake was a major challenge. Most prescriptions or start forms still arrive via fax- a reality that hasn’t changed much over the years. 

• Consent, opt-ins, and patient preferences sparked deep debate, particularly around double opt-ins, consent withdrawals, and the downstream impact on patient communications across call centers, marketing systems, and patient portals. 

• Benefits verification and prior authorizations accounted for the bulk of discussions around automation. Prior authorizations, in particular, continue to be one of the biggest drivers of delays in patient access to therapy. 

• Case notes introduced usability challenges. Users often struggled to find or interpret notes intuitively, requiring heavy customization and significant human effort to resolve. 

Advanced Therapies: A Different Scale of Complexity 

Advanced therapy companies face an even steeper challenge. 

While patient volumes may be lower, the number of tasks per patient grows exponentially due to multiple stakeholders, coordination requirements, and regulatory oversight. An autologous therapy patient journey can be 10x more complex than that of a specialty drug. 

Patient operations teams in this space need more than just another system; they need a command center– one that provides end-to-end visibility into the patient journey, eliminates the need to log into multiple disconnected platforms, and enables seamless case and task management. 

An Industry at an Inflection Point 

The life sciences industry is now at a pivotal moment. 

Advancements in technology over the past few years have opened the door to more nimble, intelligent, and scalable platforms. I see three clear opportunity areas emerging: 

1. Large pharma companies modernizing toward intelligent case management and therapy command center platforms. 

2. Small and mid-sized pharma companies re-platforming to next-generation technology- or implementing their first intelligent case management solution. 

3. Advanced therapy companies adopting intelligent command center platforms as more therapies move into commercialization. 

How We’re Addressing This at TrakCel 

At TrakCel, we’re committed to solving these challenges for our clients and the broader life sciences industry. Our approach is grounded in a deep understanding of the common, and recurring, problems faced across patient services and operations. 

We’re pursuing two complementary models: 

• Everything-in-a-Box: Designed for organizations beginning their digital journey and looking for a comprehensive, ready-to-deploy solution. 

• On-Demand: Built for companies with an existing technology ecosystem that want to scale, modernize, or augment their capabilities without disruption. 

As patient journeys become more complex and expectations continue to rise, intelligent case management and therapy command centers will no longer be optional- they’ll be essential.